
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1027 | 928 | 1027 | 882 | 1225 | 1906 |
Fund Return | 2.73% | -7.17% | 2.73% | -4.11% | 4.15% | 6.66% |
Place in category | 600 | 677 | 600 | 483 | 112 | 31 |
% in Category | 90 | 93 | 90 | 84 | 25 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF A | 44.03M | 2.73 | -4.11 | 6.66 | ||
B Multistock Swiss Stock Fund CHF C | 16.24M | 3.51 | -3.39 | 7.46 | ||
Multiflex S Carnot Efficient Energc | 100.89M | 5.19 | 0.91 | 3.44 | ||
Popso Suisse Investment Fund S Glob | 92.69M | 2.14 | -0.41 | 1.89 | ||
S CEAMS Quality Switzerland Equityb | 59.6M | 4.09 | -6.57 | 4.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.71B | 11.69 | 5.78 | 7.07 | ||
Pictet CH Institutional Swiss EquiI | 2.27B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquZD | 2.27B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiP | 2.27B | 8.84 | 1.85 | 7.84 | ||
Pictet CH Institutional Swiss EquiZ | 2.27B | 8.90 | 2.54 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.62 | 97.12 | +1.48% | |
Roche Holding Participation | CH0012032048 | 6.08 | 313.30 | +5.67% | |
Nestle | CH0038863350 | 5.33 | 89.76 | +1.31% | |
ABB | CH0012221716 | 5.20 | 49.53 | +1.39% | |
Holcim | CH0012214059 | 4.99 | 98.96 | +1.79% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review